|
TTC30A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.363000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.424200E-04 |
| Normal-vs-Stage2 |
4.682700E-03 |
| Normal-vs-Stage3 |
4.757200E-01 |
| Normal-vs-Stage4 |
5.295800E-01 |
| Stage1-vs-Stage2 |
7.016400E-01 |
| Stage1-vs-Stage3 |
2.305600E-01 |
| Stage1-vs-Stage4 |
2.617600E-01 |
| Stage2-vs-Stage3 |
3.344800E-01 |
| Stage2-vs-Stage4 |
5.066000E-01 |
| Stage3-vs-Stage4 |
9.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.380600E-04 |
| Normal-vs-AfricanAmerican |
6.426000E-04 |
| Normal-vs-Asian |
3.202300E-02 |
| Caucasian-vs-AfricanAmerican |
4.086800E-01 |
| Caucasian-vs-Asian |
7.060600E-01 |
| AfricanAmerican-vs-Asian |
8.764400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.02479999999295E-05 |
| Normal-vs-Female |
2.680400E-01 |
| Male-vs-Female |
1.181610E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.139600E-02 |
| Normal-vs-Extreme_Weight |
4.12330000000294E-05 |
| Normal-vs-Obese |
2.695600E-03 |
| Normal-vs-Extreme_Obese |
1.118800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.147400E-01 |
| Normal_Weight-vs-Obese |
8.418000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.372200E-01 |
| Extreme_Weight-vs-Obese |
8.358100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.581200E-01 |
| Obese-vs-Extreme_Obese |
7.546000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.435700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.513500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.21269999999274E-05 |
| Normal-vs-Age(81-100Yrs) |
1.026110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.228400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.521200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.594400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.157600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.621800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.349600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.039790E-04 |
| Normal-VS-Type2 PRCC |
6.299700E-02 |
| Normal-VS-KIRP CIMP |
5.764000E-03 |
| Normal-VS-Unclassified PRCC |
1.386630E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.842550E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.290200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.407500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.965820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.086800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.841620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.641500E-04 |
| Normal-vs-N1 |
8.589600E-01 |
| Normal-vs-N2 |
4.014000E-02 |
| N0-vs-N1 |
7.733800E-02 |
| N0-vs-N2 |
7.240000E-01 |
| N1-vs-N2 |
6.613900E-02 |
|
|
